Calsona, Mia Monique A.

HRN: 28-42-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2026
CLINDAMYCIN 300MG (CAP)
02/27/2026
03/05/2026
ORAL
300mg
TID X 7days
Wound Dihescence
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: